MCC Group to Discuss Using ML and AI to Support the Clinical Trial Enterprise

Monday, February 15, 2021

The MCC Artificial Intelligence / Machine Learning Community of Practice Group will host a panel discussion on 23 March to explore the topic: Using Machine Learning and AI to Support the Clinical Trial Enterprise. 

Panel Moderator: Keith Dorricott, MCC Ambassador

Panelists:

  • Ashley Howard, Associate Director, Asset Lead, Pfizer
  • Jonathan Rowe, Head of R&D Quality and Risk Management, ZS Associates

Following the panel discussion, meeting participants will have the opportunity to ask questions and discuss the topic in further detail.

Additional information about this MCC member group can be found by visiting the MCC AI/ML Knowledge Sharing Group page. MCC Members can log onto the MCC member portal to register for the session.

Not a member? Contact Terry Holland, MCC Membership Director, to discuss membership options.